Emerging targeted therapies for castration-resistant prostate cancer.
about
Castration-resistant prostate cancer: potential targets and therapies.Controversies on individualized prostate cancer care: gaps in current practice.RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel.
P2860
Emerging targeted therapies for castration-resistant prostate cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Emerging targeted therapies for castration-resistant prostate cancer.
@ast
Emerging targeted therapies for castration-resistant prostate cancer.
@en
type
label
Emerging targeted therapies for castration-resistant prostate cancer.
@ast
Emerging targeted therapies for castration-resistant prostate cancer.
@en
prefLabel
Emerging targeted therapies for castration-resistant prostate cancer.
@ast
Emerging targeted therapies for castration-resistant prostate cancer.
@en
P2093
P2860
P356
P1476
Emerging targeted therapies for castration-resistant prostate cancer.
@en
P2093
Giuseppe Chiofalo
Giuseppe Toscano
Laura Noto
Maria Picciotto
Nicola Caristi
Tindara Franchina
Vincenzo Adamo
P2860
P356
10.3389/FENDO.2012.00073
P577
2012-05-31T00:00:00Z